Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria

NCT01378286 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

DRUG: ARTESUNATE + AMODIAQUINE
DRUG: Chloroquine

Sponsor

Sanofi